http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H029815-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate | 1989-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68bcc6e7a00d147c6400c861eb75d4e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5133b66c862eab2cd7a35915fe854351 |
| publicationDate | 1990-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H029815-A |
| titleOfInvention | Osmotic continuous dispensing oral delivery system containing pharmaceutically permissible active agent having improved core membrane adhesion property |
| abstract | PURPOSE: To obtain the subject oral delivery system by providing an individual inner layer comprising a water-soluble coating film on a tablet core containing a metoprolol salt and providing a semi-permeable external layer surrounding the inner layer and adhesively bonded to an attached material. n CONSTITUTION: This oral delivery system comprises (A) a tablet core containing 5-20% tablet binder (e.g. poly-N-vinylpyrrolidone), 1-5% tablet lubricant (e.g. magnesium stearate), 0-75% osmotically active transferring agent (e.g. sugar alcohol) and the balance properly water-soluble metoprolol salt, preferably metoprolol fumarate, (B) individual internal layer of water-soluble and uniform coating in an amount of 0.3-10%, preferably 0.2-5% and (C) individual semi-permeable external layer surrounding the component B and bonded to an attached material, being impermeable to metoprolol and permeable to gastrointestinal juice and (D) one passageway through the layers B and C in communication with the component A and the external environment. n COPYRIGHT: (C)1990,JPO |
| priorityDate | 1988-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.